系统性硬化症相关雷诺现象的结构域报告:OMERACT范围综述
该范围综述评估了系统性硬化症相关雷诺现象(SSc-RP)临床研究中研究的结果结构域和使用的结局测量工具,共纳入58项研究(其中24项为随机对照试验),最常见的结果结构域为发作严重程度(n=35)、发作频率(n=28)和发作持续时间(n=19),结论认为所用结局结构域广泛且各研究间存在差异,该结果将为OMERACT系统性硬化症血管疾病工作组建立核心结构域集提供信息。
要点
- 共纳入58项研究,其中24项为随机对照试验。
- 最常见结构域为发作严重程度(n=35)、发作频率(n=28)和发作持续时间(n=19)。
- 数字灌注的客观评估在SSc-RP研究中亦常用。
核心结论
- 用于评估SSc-RP研究影响的结局结构域及相关结局广泛且在各研究间存在差异。
- 本研究结果将为OMERACT系统性硬化症血管疾病工作组建立涵盖SSc中RP影响的核心疾病结构域集提供信息。
研究设计与样本
- 范围综述,检索Embase、MEDLINE和Cochrane对照试验中心注册库,纳入成人SSc相关RP的随机对照试验、准随机研究、病例对照研究、前瞻性和回顾性队列研究、病例系列和横断面研究,要求英文发表,影像学研究至少25例参与者、问卷研究至少40例参与者,排除基础实验室和遗传学研究,不限干预、对照或研究设置。
主要发现
- 最终分析共纳入58项研究,其中24项为随机对照试验。
- 最常见的结果结构域为发作严重程度(n=35)、发作频率(n=28)和发作持续时间(n=19)。
- 数字灌注的客观评估在SSc-RP研究中亦常用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Raynaud's phenomenon (RP) is a cardinal feature of SSc and is associated with significant disease-related morbidity that impacts on quality of life. The assessment of SSc-RP is challenging. The aim of this scoping review was to evaluate the outcome domains studied and outcome measures used in clinical studies of SSc-RP. METHODS: Embase, MEDLINE, and the Cochrane Central Register of Controlled Trials were used to identify randomized control trials (RCTs), quasi-randomized studies, case-control studies, prospective and retrospective cohort studies, case series, and cross-sectional studies of adult participants with SSc-associated RP, written in English. A minimum of 25 participants for studies of imaging modalities and 40 participants for questionnaire-based studies was required for inclusion. Basic laboratory and genetic studies were excluded. No limitations were imposed based on intervention, comparator, or study setting. Study characteristics and primary and secondary target domains in each study were recorded. RESULTS: 58 studies (24 randomized clinical trials) were included in the final analysis. The commonest domains captured were severity of attacks (n=35), frequency of attacks (n=28), and duration of attacks (n=19). Objective assessments of digital perfusion were also commonly used in studies of SSc-RP. CONCLUSION: The outcome domains and the associated outcomes used to assess the impact of SSc-RP in research studies are broad and have varied across studies. The results of this study will inform the OMERACT Vascular Disease in Systemic Sclerosis Working Group to establish a core set of disease domains encompassing the impact of RP in SSc.
引用
- Maltez N, Hughes M, Brown E, et al. Domain reporting in systemic sclerosis-related Raynaud's phenomenon: An OMERACT scoping review. Semin Arthritis Rheum. 2023. PMID: 37202251. doi:10.1016/j.semarthrit.2023.152208
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。